drugset / Trial / NCT05329116

Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis

NCT05329116

Unknown 42 enrolled Necmettin Yildiz
RandomizedParallel-groupSingle-blindTreatment

Summary

In this study, the investigators aimed to determine whether platelet rich plasma (PRP) and mesotherapy combined treatment is effective on pain and function compared to PRP alone in patients with knee osteoarthritis (OA).

Timeline

Start
2022-05-15
Primary completion
2022-10-25
Completion
2022-12-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1.5 ml Other
Comparator Pentoxifylline Small molecule 30 mg Other
Comparator Platelet Rich Plasma Other / unclassified Other

Indications